TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Leo Pharma AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 105,491 | 126,062 | 139,512 |
Financial expenses | 1,553 | 304 | 425 |
Earnings before taxes | 4,140 | 5,689 | 6,291 |
EBITDA | 4,374 | 6,037 | 6,580 |
Total assets | 88,371 | 151,858 | 75,498 |
Current assets | 83,069 | 140,850 | 64,216 |
Current liabilities | 54,700 | 71,136 | 39,057 |
Equity capital | 19,922 | 18,529 | 14,464 |
- share capital | 668 | 727 | 741 |
Employees (average) | 18 | 31 | 35 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 22.5% | 12.2% | 19.2% |
Turnover per employee | 5,861 | 4,067 | 3,986 |
Profit as a percentage of turnover | 3.9% | 4.5% | 4.5% |
Return on assets (ROA) | 6.4% | 3.9% | 8.9% |
Current ratio | 151.9% | 198.0% | 164.4% |
Return on equity (ROE) | 20.8% | 30.7% | 43.5% |
Change turnover | -10,360 | -10,809 | -8,410 |
Change turnover % | -9% | -8% | -6% |
Chg. No. of employees | -13 | -4 | 1 |
Chg. No. of employees % | -42% | -11% | 3% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.